Association of a Kaposi's Sarcoma Herpes Virus gene with B cell Lymphoma Provides Possible Clues for Therapy
Notice bibliographique
Résumé
AbstractResearch showing how Kaposi sarcoma-associated herpes virus (KSHV) induced a pre-lymphoma condition, and in some cases true lymphoma in mice, represents a major breakthrough in understanding the genesis of this particular type of blood cancer.The findings are featured as the cover story in march, 2006 in the Journal of Clinical Investigation. The research was led by Dirk Dittmer, Ph.D., University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, and funded by The Leukemia & Lymphoma Society.Dr. Dittmer's work shows that a particular viral gene in the KSHV caused the pre-malignant and malignant changes, further suggesting that this gene might be a novel disease marker and a valid target for anti-lymphoma therapy. Because only the cancer cells carry the virus, one or more of the existing anti-viral therapies might help patients with this particular type of B cell lymphoma, and specific gene tests might be used to predict if patients with virally-associated lymphomas will benefit from treatment with anti-viral drugs.Dr. Dittmer is a recipient of a Translational Research Grant from the Society, a program that supports outstanding investigative research showing strong promise of translating basic biomedical knowledge into new and better treatments for blood cancers. The program's goal is to accelerate the transfer of findings from the laboratory to clinical application, ultimately prolonging and enhancing patients' lives."The goal of the Translational Research Program is to provide researchers with the resources to advance diagnosis, prevention or treatment of blood cancers in the near term," said Marshall Lichtman, M.D., executive vice president, Research & Medical Programs. "Dr. Dittmer's research may lead to earlier diagnosis, potentially prevention and provide the insights to develop a better treatment for a particular group of lymphoma patients."Dr. Dittmer said that the Society's support was fundamental in moving his research forward."I am truly grateful to The Leukemia & Lymphoma Society for having confidence in my work and providing me with this funding," said Dr. Dittmer. "I am hopeful that our work studying how herpes viruses alter normal immune cells in biology to create malignancies will help determine whether certain lymphoma patients might respond to anti-viral therapy."About The Leukemia & Lymphoma SocietyThe Leukemia & Lymphoma Society, headquartered in White Plains, NY, with 66 chapters in the United States and Canada, is the world's largest voluntary health organization dedicated to funding blood cancer research and providing education and patient services. The Society's mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. Since its founding in 1949, the Society has invested more than $424 million in research specifically targeting leukemia, lymphoma and myeloma. Last year alone, the Society made 2.5 million contacts with patients, caregivers and healthcare professionals.For more information about blood cancer, visit www.LLS.org or call the Society's Information Resource Center (IRC), a call center staffed by master's level social workers, nurses and health educators who provide information, support and resources to patients and their families and caregivers. IRC information specialists are available at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET.
Récupéré en direct depuis OpenAlex et désinversé. Les résumés ne sont pas conservés dans cette base de données : les index inversés représentent 8,6 Go des 9,3 Go de texte de la base, et le serveur dispose de 13 Go libres.
Comment cette classification a été obtenuedéplier
Prédiction distillée sur la base complète
Imitation des enseignantsNi prévalence calibrée, ni vérité terrain. Validation humaine à venir. Apprise à partir de 10 348 étiquettes directes de Codex et de 10 348 étiquettes directes de Gemma. Le mode candidate est l'union des têtes enseignantes seuillées; le consensus est leur intersection. Ces sorties portent le statut machine_predicted_unvalidated et ne sont ni des étiquettes humaines ni des étiquettes directes de modèles de pointe.
Scores Codex et Gemma par catégorie
| Catégorie | Codex | Gemma |
|---|---|---|
| Métarecherche | 0,000 | 0,000 |
| Méta-épidémiologie (sens strict) | 0,000 | 0,000 |
| Méta-épidémiologie (sens large) | 0,001 | 0,000 |
| Bibliométrie | 0,000 | 0,000 |
| Études des sciences et des technologies | 0,000 | 0,000 |
| Communication savante | 0,000 | 0,000 |
| Science ouverte | 0,000 | 0,000 |
| Intégrité de la recherche | 0,000 | 0,000 |
| Charge utile insuffisante (le modèle a refusé de juger) | 0,000 | 0,000 |
Scores machine (provisoires)
Les deux têtes enseignantes du modèle étudiant, lues sur ce travail. Un score ordonne la base pour la relecture; il n'affirme jamais une catégorie, et le statut de validation accompagne chaque rangée tel quel.
Scores de référence d'un modèle non mature (critères de maturité non atteints, 7 itérations). Un score ordonne; il n'affirme jamais une catégorie.
score_only:v0-immature-baseline · tel quel depuis la passe de notation : score_only signifie que le nombre peut ordonner les travaux, et qu'aucune étiquette de catégorie n'en découleClassification
machine, non validéePrédiction automatique; un appel candidat d’une seule tête enseignante, pas un consensus.
Le détail, modèle par modèle et score par score, se trouve en fin de page sous « Comment cette classification a été obtenue ».